Subscribe To
Panbela to host third quarter 2023 earnings conference call on november 9, 2023
MINNEAPOLIS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical...
October 24, 2023, 8:15 am
Arbutus to report third quarter 2023 financial results and provide corporate update
WARMINSTER, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a ...
October 24, 2023, 7:30 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Circling bank on tango therapeutics
We are circling back on clinical stage developmental concern Tango Therapeutics, Inc. for the first tim...
October 23, 2023, 6:26 pm
Merck & co. inc. (mrk) merck & co. announced collaboration with daiichi sankyo and esmo investor event (transcript)
Merck & Co. Inc. (NYSE:MRK ) October 22, 2023 1:00 PM ET Company Participants Peter Dannenbaum - VP, IR Dr. Dean Li - President, Merck Research Labs E...
October 23, 2023, 11:32 am
Harpoon therapeutics stock soars on ‘promising' lung cancer drug results
Harpoon Therapeutics Inc shares surged as much as 40% in pre-market trading on Monday after the clinical...
October 23, 2023, 9:32 am
Filament health jv magdalena biosciences kicks off preclinical study of plant extracts for mental health indications
Filament Health Corp (OTCQB:FLHLF, NEO:FH) said Magdalena Biosciences, its joint venture (JV) with Jaguar Health, has initiated a pre...
October 23, 2023, 9:03 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceuti...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceuti...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceuti...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceuti...
October 23, 2023, 5:00 am
Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceuti...
October 23, 2023, 5:00 am